Kezar Life Sciences, Inc.
Biotechnology · Healthcare
Equibles does not estimate personal net worth.
The proxy statement of Kezar Life Sciences, Inc. reports total compensation of $2,198,505 for Noreen Roth Henig in fiscal 2023, including a base salary of $404,417. Disclosed compensation is on record for 4 fiscal years.
Kezar Life Sciences, Inc.
Proxy statement
Start not stated–2023-10-06
Kezar Life Sciences, Inc.
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Kezar Life Sciences, Inc. | Former Chief Medical Officer | $404,417 | $2,198,505 |
| 2022 | Kezar Life Sciences, Inc. | Former Chief Medical Officer | $500,000 | $2,621,344 |
| 2021 | Kezar Life Sciences, Inc. | Chief Medical Officer | $475,000 | $1,811,616 |
| 2020 | Kezar Life Sciences, Inc. | Chief Medical Officer | $286,667 | $1,459,001 |
No call appearances or filed executive changes recorded yet.